Somatostatin News and Research

RSS
Study examines how fear responses are learned, controlled and memorized

Study examines how fear responses are learned, controlled and memorized

FDA approves Novartis Signifor injection for treatment of Cushing's disease

FDA approves Novartis Signifor injection for treatment of Cushing's disease

Radiopharmaceutical Tektrotyd continues to receive interest and recognition

Radiopharmaceutical Tektrotyd continues to receive interest and recognition

FDA EMDAC votes unanimously in support of Signifor use for treatment of Cushing's disease

FDA EMDAC votes unanimously in support of Signifor use for treatment of Cushing's disease

Two major classes of brain cells repress neural activity in specific mathematical ways

Two major classes of brain cells repress neural activity in specific mathematical ways

Novartis’ pasireotide offers symptom relief for patients with advanced neuroendocrine tumors

Novartis’ pasireotide offers symptom relief for patients with advanced neuroendocrine tumors

Novel multireceptor-targeted somatostatin analogue found effective against neuroendocrine tumors

Novel multireceptor-targeted somatostatin analogue found effective against neuroendocrine tumors

Researchers use metal complexes to modify peptide hormones

Researchers use metal complexes to modify peptide hormones

New somatostatin vaccines promote weight loss

New somatostatin vaccines promote weight loss

Combination treatment improves progression-free survival in pancreatic neuroendocrine tumors

Combination treatment improves progression-free survival in pancreatic neuroendocrine tumors

New guidelines for the treatment of acromegaly, a serious growth hormone disorder

New guidelines for the treatment of acromegaly, a serious growth hormone disorder

New Acromegaly clinical practice guidelines

New Acromegaly clinical practice guidelines

Molecular radiotherapy offers hope for children with neuroblastoma

Molecular radiotherapy offers hope for children with neuroblastoma

Octreotide inhibits HepG2 proliferation, study confirms

Octreotide inhibits HepG2 proliferation, study confirms

Ipsen discontinues development of chimeric compound BIM 23A760 for acromegaly

Ipsen discontinues development of chimeric compound BIM 23A760 for acromegaly

Phase 3 study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors

Phase 3 study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors

Ipsen announces sale of shares in PregLem Holding to Gedeon Richter

Ipsen announces sale of shares in PregLem Holding to Gedeon Richter

Hyponatremia may lead to neurological complications

Hyponatremia may lead to neurological complications

Chiasma successfully completes Phase I clinical study of Octreolin

Chiasma successfully completes Phase I clinical study of Octreolin

Hormone mimic Octreotide promising for treatment of polycystic liver disease caused by ADPKD: Study

Hormone mimic Octreotide promising for treatment of polycystic liver disease caused by ADPKD: Study